Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2009 1
2012 1
2015 1
2017 1
2018 1
2019 1
2020 1
2021 3
2022 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases.
Do LD, Moritz CP, Muñiz-Castrillo S, Pinto AL, Tholance Y, Brugiere S, Couté Y, Stoevesandt O, Taussig MJ, Rogemond V, Vogrig A, Joubert B, Ferraud K, Camdessanché JP, Antoine JC, Honnorat J. Do LD, et al. Among authors: ferraud k. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 28;8(5):e1032. doi: 10.1212/NXI.0000000000001032. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34321331 Free PMC article.
Anti-AGO1 Antibodies Identify a Subset of Autoimmune Sensory Neuronopathy.
Moritz CP, Tholance Y, Vallayer PB, Do LD, Muñiz-Castrillo S, Rogemond V, Ferraud K, La Marca C, Honnorat J, Killian M, Paul S, Camdessanché JP, Antoine JG. Moritz CP, et al. Among authors: ferraud k. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 18;10(3):e200105. doi: 10.1212/NXI.0000000000200105. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37072227 Free article.
Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies.
Tholance Y, Moritz CP, Rosier C, Ferraud K, Lassablière F, Reynaud-Federspiel E, França MC Jr, Martinez ARM, Camdessanché JP, Antoine JC; anti-FGFR3 antibody Study Group. Tholance Y, et al. Among authors: ferraud k. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):49-57. doi: 10.1136/jnnp-2019-321849. Epub 2019 Nov 5. J Neurol Neurosurg Psychiatry. 2020. PMID: 31690697
Antiganglioside antibodies in paraneoplastic peripheral neuropathies.
Antoine JC, Camdessanché JP, Ferraud K, Caudie C. Antoine JC, et al. Among authors: ferraud k. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1765-7. doi: 10.1136/jnnp.2003.032193. J Neurol Neurosurg Psychiatry. 2004. PMID: 15548502 Free PMC article.
Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.
Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group. Svahn J, et al. Among authors: ferraud k. J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. doi: 10.1136/jnnp-2017-316715. Epub 2017 Oct 25. J Neurol Neurosurg Psychiatry. 2018. PMID: 29070644 Clinical Trial.
Expression of the onconeural CV2/CRMP5 antigen in thymus and thymoma.
Camdessanché JP, Lassablière F, Meyronnet D, Férraud K, Absi L, Honnorat J, Antoine JC. Camdessanché JP, et al. Among authors: ferraud k. J Neuroimmunol. 2006 May;174(1-2):168-73. doi: 10.1016/j.jneuroim.2006.01.018. Epub 2006 Mar 7. J Neuroimmunol. 2006. PMID: 16519949
12 results